PHARMAQ, an industry leader in the manufacturing and distribution of fish vaccines for aquaculture, is currently planning to relocate their viral antigen manufacturing facility.
io-consultants jointly developed a general concept with PHARMAQ for a new viral antigen facility with single-use process technology. Emphasis was on increasing process safety and minimizing investment cost by closed aseptic processing. The outcome is a flexible, modular building concept with optimized personnel and material flow. Also io-consultants was supporting PHARMAQ in their site selection process for the new facility.